Global AI Powered Cancer Diagnostics Market 2022-2027

    Multi User License - $2,800

    In Stock

    Coming Soon

    GLOBAL AI POWERED CANCER DIAGNOSTICS MARKET

     

    INTRODUCTION

     

    AI algorithms that can identify ever-smaller lung tumours have been developed in response to the requirement for early diagnosis. Because of the limitations of human eyesight, radiologists are prone to overlooking small cancerous tumours. For example, up to 35% of lung nodules are overlooked during the first examination.

     

    infographic- AI Powered Cancer Diagnostic Market, AI Powered Cancer Diagnostic Market Size, AI Powered Cancer Diagnostic Market Trends, AI Powered Cancer Diagnostic Market Forecast, AI Powered Cancer Diagnostic Market Risks, AI Powered Cancer Diagnostic Market Report, AI Powered Cancer Diagnostic Market Share

     

    AI technology can help on both counts by taking part of the load off of overworked professionals and finding lung spots that aren’t evident to the human eye. Computer-assisted diagnostic technologies are already used by radiologists to help them detect malignant tumours. 

     

    GLOBAL AI POWERED CANCER DIAGNOSTICS MARKET DEVELOPMENTS AND INNOVATIONS

     

    S No Overview of Development Development Detailing Region of Development Possible Future Outcomes
    1 Siemens signed an agreement with Geisinger, a healthcare provider Access to diagnostic imaging equipment and artificial intelligence applications was the focus of the deal. Global This would enhance better Technological Controls
    2 Aidoc teamed up with LucidHealth, a physician-owned and led radiology company The goal of this partnership was for the latter firm to deploy an AI-powered diagnostic tool developed by the former to assist prioritise and speed treatment for patients with urgent, life-threatening diseases. Global This would enhance better Technological Controls
    3 Zebra Medical Vision announced its collaboration with Johnson & Johnson’s DePuy Synthes. The goal of the partnership was to provide Cloud-based AI solutions to the orthopaedic and bone health industries together. Global This would enhance better Technological Controls
    4 AI and machine learning could improve cancer diagnosis through biomarker discovery These technologies are now being used to tackle the problems of cancer biomarker identification, where the analysis of massive volumes of imaging and molecular data exceeds the capabilities of classic statistical analyses and tools. Global This would enhance better Technological Controls
    5 Artificial Intelligence System Improves Breast Cancer Detection Scientists from NYU and NYUAD have built a revolutionary artificial intelligence (AI) system that reaches radiologist-level reliability, according to a recent study. Global This would enhance better Technological Controls

     

    GLOBAL AI POWERED CANCER DIAGNOSTIC MARKET SIZE AND FORECAST

     

    The Global AI Powered Cancer Diagnostic Market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2027, registering a CAGR of XX% from 2022 to 2027.

     

    COMPETITIVE LANDSCAPE

     

    Scientists are discovering new methods to use artificial intelligence (AI) in the healthcare area as it keeps expanding. AI has played a key role in the diagnosis, decision-making, and treatment of chronic diseases, particularly in medical research.

     

    AI integration in precision medicine might enhance diagnostic efficiency and accuracy, help healthcare decision, and result in improved healthcare outcomes. Clinical care driven by AI has the potential to significantly reduce health inequities, especially in the low environments.

     

    GE Healthcare a leading mobiliser of the Mobility solutions involving cancer solutions orienting towards AI Cancer requirements in the market. It detects and assesses the likelihood of malignancy in a lung nodule, which is crucial for assessing whether or not a biopsy is required and for speeding up diagnosis.

     

    It’s the first AI-assisted diagnostic programme approved by the FDA for early-stage lung cancer, and it’s been demonstrated to enhance the high sensitivity of undetermined nodular aggressiveness evaluations.

     

    Siemens AG is part of the component manufacture trending companies in the current industry. Its latest addition has been brought in through the AI-Pathway Companion Lung Cancer aids multidimensional teams (MDT) by centralising patient care and case reviews on an unified platform, offering data quality assurance, and allowing for the production of clinically important patient-specific footnotes. This is a waste of time and effort for all MDT participants.

     

    COMPANIES PROFILED

     

    THIS REPORT WILL ANSWER FOLLOWING QUESTIONS

    1. What is the average selling price in the Global AI Powered Cancer Diagnostic Market right now and how will it change in the next 5-6 years? 
    2. Market share of Global AI Powered Cancer Diagnostic Market manufacturers and their upcoming products
    3. Cost advantage for OEMs who manufacture Global AI Powered Cancer Diagnostic Market in-house.
    4. 5 key predictions for next 5 years in Global AI Powered Cancer Diagnostic Market
    5. Latest trends in Global AI Powered Cancer Diagnostic Market, by every market segment
    6. The market size (both volume and value) of Global AI Powered Cancer Diagnostic Market in 2022-2027 and every year in between
    7. Global production breakup of Global AI Powered Cancer Diagnostic Market, by suppliers and their OEM relationship
    8. What is happening overall in the Global AI Powered Cancer Diagnostic Market.
    9. Who are the major players in the Global AI Powered Cancer Diagnostic Market.
    10. What are the business opportunities in the Global AI Powered Cancer Diagnostic Market?
    11. What is the target group for the Global AI Powered Cancer Diagnostic Market?
    12. What are the strategies for the Global AI Powered Cancer Diagnostic Market in the next 5 years?

     

    Sl no  Topic 
    Market Segmentation 
    Scope of the report 
    Abbreviations 
    Research Methodology 
    Executive Summary 
    Introduction 
    Insights from Industry stakeholders 
    Cost breakdown of Product by sub-components and average profit margin 
    Disruptive innovation in the Industry 
    10  Technology trends in the Industry 
    11  Consumer trends in the industry 
    12  Recent Production Milestones 
    13  Component Manufacturing in US, EU and China 
    14  COVID-19 impact on overall market 
    15  COVID-19 impact on Production of components 
    16  COVID-19 impact on Point of sale 
    17  Market Segmentation, Dynamics and Forecast by Geography, 2022-2027 
    18  Market Segmentation, Dynamics and Forecast by Product Type, 2022-2027 
    19  Market Segmentation, Dynamics and Forecast by Application, 2022-2027 
    20  Market Segmentation, Dynamics and Forecast by End use, 2022-2027 
    21  Product installation rate by OEM, 2022 
    22  Incline/Decline in Average B-2-B selling price in past 5 years 
    23  Competition from substitute products 
    24  Gross margin and average profitability of suppliers 
    25  New product development in past 12 months 
    26  M&A in past 12 months 
    27  Growth strategy of leading players 
    28  Market share of vendors, 2022 
    29  Company Profiles 
    30  Unmet needs and opportunity for new suppliers 
    31  Conclusion 
    32  Appendix 
    0
      0
      Your Cart
      Your cart is emptyReturn to Shop